Skip to content
Middletown Life
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
OKYO Pharma LTD
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
February 13, 2026
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
February 12, 2026
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
February 8, 2026
OKYO Pharma Announces Successful Type C Meeting with the FDA
January 28, 2026
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
January 23, 2026
←
Previous Page
1
2